HMO giant Kaiser Permanente has given ADAC Laboratories an exclusivethree-year contract to supply nuclear medicine equipment to 17hospitals in its northern California region. ADAC, of Milpitas,CA, believes the contract could be worth up to $10 million.
HMO giant Kaiser Permanente has given ADAC Laboratories an exclusivethree-year contract to supply nuclear medicine equipment to 17hospitals in its northern California region. ADAC, of Milpitas,CA, believes the contract could be worth up to $10 million.
In other ADAC news, the company announced last month that itis taking another crack at the Malcolm Baldridge National QualityAward, which is presented annually by the U.S. Department of Commerceto recognize excellence in business management and performance.ADAC was one of six finalists for the award last year, but theCommerce Department ultimately chose not to present the award.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.